{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:31:28Z","timestamp":1793107888925,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Atrial fibrillation (AF) is prevalent in patients with type 2 diabetes mellitus (T2DM). Glycemic variability (GV) is associated with risk of micro- and macrovascular diseases. However, whether the GV can increase the risk of AF remains unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The cohort study used a database from National Taiwan University Hospital, a tertiary medical center in Taiwan. Between 2014 and 2019, a total of 27,246 adult patients with T2DM were enrolled for analysis. Each individual was assessed to determine the coefficients of variability of fasting glucose (FGCV) and HbA1c variability score (HVS). The GV parameters were categorized into quartiles. Multivariate Cox regression models were employed to estimate the relationship between the GV parameters and the risk of AF, transient ischemic accident (TIA)\/ischemic stroke and mortality in patients with T2DM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The incidence rates of AF and TIA\/ischemic stroke were 21.31 and 13.71 per 1000 person-year respectively. The medium follow-up period was 70.7\u00a0months. In Cox regression model with full adjustment, the highest quartile of FGCV was not associated with increased risk of AF [Hazard ratio (HR): 1.12, 95% confidence interval (CI) 0.96\u20131.29, p\u2009=\u20090.148] or TIA\/ischemic stroke (HR: 1.04, 95% CI 0.83\u20131.31, p\u2009=\u20090.736), but was associated with increased risk of total mortality (HR: 1.33, 95% CI 1.12\u20131.58, p\u2009&lt;\u20090.001) and non-cardiac mortality (HR: 1.41, 95% CI 1.15\u20131.71, p\u2009&lt;\u20090.001). The highest HVS was significantly associated with increased risk of AF (HR: 1.29, 95% CI 1.12\u20131.50, p\u2009&lt;\u20090.001), total mortality (HR: 2.43, 95% CI 2.03\u20132.90, p\u2009&lt;\u20090.001), cardiac mortality (HR: 1.50, 95% CI 1.06\u20132.14, p\u2009=\u20090.024) and non-cardiac mortality (HR: 2.80, 95% CI 2.28\u20133.44, p\u2009&lt;\u20090.001) but was not associated with TIA\/ischemic stroke (HR: 0.98, 95% CI 0.78\u20131.23, p\u2009=\u20090.846). The Kaplan\u2013Meier analysis showed significantly higher risk of AF, cardiac and non-cardiac mortality according to the magnitude of GV (log-rank\u2009test,\u00a0p\u00a0&lt;\u20090.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our data demonstrate that high GV is independently associated with the development of new-onset AF in patients with T2DM. The benefit of maintaining stable glycemic levels to improve clinical outcomes warrants further studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-021-01341-3","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T15:03:11Z","timestamp":1627052591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Higher long-term visit-to-visit glycemic variability predicts new-onset atrial fibrillation in patients with diabetes mellitus"],"prefix":"10.1186","volume":"20","author":[{"given":"Jung-Chi","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Yun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Lin","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Chieh","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9281-1171","authenticated-orcid":false,"given":"Lian-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,23]]},"reference":[{"issue":"1","key":"1341_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12933-019-0983-1","volume":"19","author":"SS Ahmadi","year":"2020","unstructured":"Ahmadi SS, Svensson AM, Pivodic A, et al. Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: a Swedish cohort study. Cardiovasc Diabetol. 2020;19(1):9.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"1341_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jdiacomp.2018.02.004","volume":"32","author":"D Aune","year":"2018","unstructured":"Aune D, Feng T, Schlesinger S, et al. Diabetes mellitus, blood glucose and the risk of atrial fbrillation: a system atic review and meta-analysis of cohort studies. J Diabet Complicat. 2018;32(5):501\u201311.","journal-title":"J Diabet Complicat"},{"key":"1341_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.hroo.2020.05.002","volume":"1","author":"HJ Jansen","year":"2020","unstructured":"Jansen HJ, Bohne LJ, Gillis AM, et al. Atrial remodeling and atrial fibrillation in acquired forms of cardiovascular disease. Heart Rhythm. 2020;1:147\u201359.","journal-title":"Heart Rhythm"},{"issue":"11","key":"1341_CR4","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.cjca.2018.08.018","volume":"34","author":"RC \u015eerban","year":"2018","unstructured":"\u015eerban RC, Scridon A. Data linking diabetes mellitus and atrial fibrillation-how strong is the evidence? From epidemiology and pathophysiology to therapeutic implications. Can J Cardiol. 2018;34(11):1492\u2013502.","journal-title":"Can J Cardiol"},{"key":"1341_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2840-12-1","volume":"12","author":"K Torimoto","year":"2013","unstructured":"Torimoto K, Okada Y, Mori H, Tanaka Y. Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus. Cardiovasc Diabetol. 2013;12:1.","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"1341_CR6","doi-asserted-by":"publisher","first-page":"18381","DOI":"10.3390\/ijms151018381","volume":"15","author":"Y Saisho","year":"2014","unstructured":"Saisho Y. Glycemic variability and oxidative stress: a link between diabetes and cardiovascular disease? Int J Mol Sci. 2014;15(10):18381\u2013406.","journal-title":"Int J Mol Sci"},{"issue":"14","key":"1341_CR7","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","volume":"295","author":"L Monnier","year":"2006","unstructured":"Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295(14):1681\u20137.","journal-title":"JAMA"},{"key":"1341_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12933-015-0233-0","volume":"14","author":"JE Jun","year":"2015","unstructured":"Jun JE, Jin SM, Baek J, et al. The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes. Cardiovasc Diabetol. 2015;14:70.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"1341_CR9","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S0735-1097(02)02972-8","volume":"41","author":"P Gresele","year":"2003","unstructured":"Gresele P, Guglielmini G, De Angelis M, et al. Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol. 2003;41(6):1013\u201320.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1341_CR10","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s12020-019-02150-1","volume":"67","author":"Pu Zhaokun","year":"2020","unstructured":"Zhaokun Pu, Lai L, Yang X, et al. Acute glycemic variability on admission predicts the prognosis in hospitalized patients with coronary artery disease: a meta-analysis. Endocrine. 2020;67(3):526\u201334.","journal-title":"Endocrine"},{"key":"1341_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12933-015-0275-3","volume":"14","author":"K Okada","year":"2015","unstructured":"Okada K, Hibi K, Gohbara M, et al. Association between blood glucose variability and coronary plaque instability in patients with acute coronary syndromes. Cardiovasc Diabetol. 2015;14:111.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1341_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12933-019-0831-3","volume":"18","author":"G Besch","year":"2019","unstructured":"Besch G, Pili-Floury S, Morel C, et al. Impact of post-procedural glycemic variability on cardiovascular morbidity and mortality after transcatheter aortic valve implantation: a post hoc cohort analysis. Cardiovasc Diabetol. 2019;18(1):27.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"1341_CR13","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1536\/ihj.18-503","volume":"60","author":"T Zhang","year":"2019","unstructured":"Zhang T, Gong Su, Mi S-H, et al. Association between blood glucose variability and the characteristics of vulnerable plaque in elderly non-ST segment elevation acute coronary syndrome patients. Int Heart J. 2019;60(3):569\u201376.","journal-title":"Int Heart J"},{"issue":"10","key":"1341_CR14","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.2337\/dc20-0838","volume":"43","author":"W Feng","year":"2020","unstructured":"Feng W, Li Z, Guo W, et al. Association between fasting glucose variability in young adulthood and the progression of coronary artery calcification in middle age. Diabetes Care. 2020;43(10):2574\u201380.","journal-title":"Diabetes Care"},{"issue":"1","key":"1341_CR15","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12933-019-0971-5","volume":"18","author":"S Yokota","year":"2019","unstructured":"Yokota S, Tanaka H, Mochizuki Y, et al. Association of glycemic variability with left ventricular diastolic function in type 2 diabetes mellitus. Cardiovasc Diabetol. 2019;18(1):166.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"1341_CR16","doi-asserted-by":"publisher","first-page":"486","DOI":"10.2337\/dc18-1430","volume":"42","author":"JB Echouffo-Tcheugui","year":"2019","unstructured":"Echouffo-Tcheugui JB, Zhao S, Brock G, et al. Visit-to-visit glycemic variability and risks of cardiovascular events and all-cause mortality: the ALLHAT study. Diabetes Care. 2019;42(3):486\u201393.","journal-title":"Diabetes Care"},{"issue":"8","key":"1341_CR17","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.2337\/dc19-2541","volume":"43","author":"MW Segar","year":"2020","unstructured":"Segar MW, Patel KV, Vaduganathan M, et al. Association of long-term change and variability in glycemia with risk of incident heart failure among patients with type 2 diabetes: a secondary analysis of the ACCORD trial. Diabetes Care. 2020;43(8):1920\u20138.","journal-title":"Diabetes Care"},{"issue":"12","key":"1341_CR18","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.2337\/dc18-1287","volume":"41","author":"MP Bancks","year":"2018","unstructured":"Bancks MP, Carnethon MR, Jacobs DR Jr, et al. Fasting glucose variability in young adulthood and cognitive function in middle age: the coronary artery risk development in young adults (CARDIA) study. Diabetes Care. 2018;41(12):2579\u201385.","journal-title":"Diabetes Care"},{"issue":"2","key":"1341_CR19","doi-asserted-by":"publisher","first-page":"426","DOI":"10.2337\/dc19-0823","volume":"43","author":"S Li","year":"2020","unstructured":"Li S, Nemeth I, Donnelly L, et al. Visit-to-visit HbA 1c variability is associated with cardiovascular disease and microvascular complications in patients with newly diagnosed type 2 diabetes. Diabetes Care. 2020;43(2):426\u201332.","journal-title":"Diabetes Care"},{"issue":"8","key":"1341_CR20","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.2337\/dc14-0199","volume":"37","author":"Y Hirakawa","year":"2014","unstructured":"Hirakawa Y, Arima H, Zoungas S, et al. Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial. Diabetes Care. 2014;37(8):2359\u201365.","journal-title":"Diabetes Care"},{"issue":"1","key":"1341_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12933-018-0677-0","volume":"17","author":"CRL Cardoso","year":"2018","unstructured":"Cardoso CRL, Leite NC, Moram CBM, et al. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study. Cardiovasc Diabetol. 2018;17(1):33.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1341_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.hrthm.2019.07.006","volume":"17","author":"S-R Lee","year":"2020","unstructured":"Lee S-R, Choi E-K, Han K-D, et al. Effect of the variability of blood pressure, glucose level, total cholesterol level, and body mass index on the risk of atrial fibrillation in a healthy population. Heart Rhythm. 2020;17(1):12\u20139.","journal-title":"Heart Rhythm"},{"issue":"1","key":"1341_CR23","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.hrthm.2020.08.019","volume":"18","author":"LJ Bohne","year":"2021","unstructured":"Bohne LJ, Jansen HJ, Daniel I, et al. Electrical and structural remodeling contribute to atrial fibrillation in type 2 diabetic db\/db mice. Heart Rhythm. 2021;18(1):118\u201329.","journal-title":"Heart Rhythm"},{"issue":"1","key":"1341_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/cvr\/cvu176","volume":"104","author":"S Saito","year":"2014","unstructured":"Saito S, Teshima Y, Fukui A, et al. Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats. Cardiovasc Res. 2014;104(1):5\u201314.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"1341_CR25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/1479164117698917","volume":"14","author":"C Ying","year":"2017","unstructured":"Ying C, Liu T, Ling H, et al. Glucose variability aggravates cardiac fibrosis by altering AKT signalling path. Diab Vasc Dis Res. 2017;14(4):327\u201335.","journal-title":"Diab Vasc Dis Res"},{"issue":"2","key":"1341_CR26","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.dsx.2021.03.004","volume":"15","author":"R Ravi","year":"2021","unstructured":"Ravi R, Balasubramaniam V, Kuppusamy G, et al. Current concepts and clinical importance of glycemic variability. Diabetes Metab Syndr. 2021;15(2):627\u201336.","journal-title":"Diabetes Metab Syndr"},{"issue":"8","key":"1341_CR27","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.amjcard.2014.07.045","volume":"114","author":"O Fatemi","year":"2014","unstructured":"Fatemi O, Yuriditsky E, Tsioufis C, et al. Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study). Am J Cardiol. 2014;114(8):1217\u201322.","journal-title":"Am J Cardiol"},{"issue":"7","key":"1341_CR28","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.2337\/dc10-0013","volume":"33","author":"RJ Wright","year":"2010","unstructured":"Wright RJ, Newby DE, Stirling D. Effects of acute insulin-induced hypoglycemia on indices of inflammation: putative mechanism for aggravating vascular disease in diabetes. Diabetes Care. 2010;33(7):1591\u20137.","journal-title":"Diabetes Care"},{"issue":"Suppl 2","key":"1341_CR29","doi-asserted-by":"publisher","first-page":"S132","DOI":"10.2337\/dc11-s220","volume":"34","author":"BM Frier","year":"2011","unstructured":"Frier BM, Schernthaner G, Heller SR. Hypoglycemia and cardiovascular risks. Diabetes Care. 2011;34(Suppl 2):S132\u20137.","journal-title":"Diabetes Care"},{"issue":"3","key":"1341_CR30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(18)30136-0","volume":"7","author":"A Ceriello","year":"2019","unstructured":"Ceriello A, Monnier L, Owens D. Glycaemic variability in diabetes: clinical and therapeutic implications. Lancet Diabetes Endocrinol. 2019;7(3):221\u201330.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"1341_CR31","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.2337\/dc19-2589","volume":"43","author":"C-S Sheng","year":"2020","unstructured":"Sheng C-S, Tian J, Miao Ya, et al. Prognostic significance of long-term HbA 1c variability for all-cause mortality in the ACCORD trial. Diabetes Care. 2020;43(6):1185\u201390.","journal-title":"Diabetes Care"},{"issue":"1","key":"1341_CR32","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1038\/s41598-018-37834-7","volume":"9","author":"J-Y Jang","year":"2019","unstructured":"Jang J-Y, Moon S, Cho S, et al. Visit-to-visit HbA1c and glucose variability and the risks of macrovascular and microvascular events in the general population. Sci Rep. 2019;9(1):1374.","journal-title":"Sci Rep"},{"issue":"1","key":"1341_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12933-020-01082-9","volume":"19","author":"C-Y Yang","year":"2020","unstructured":"Yang C-Y, Pei-Fang Su, Hung J-Y, et al. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes. Cardiovasc Diabetol. 2020;19(1):105.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"1341_CR34","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/dme.13435","volume":"35","author":"JD Noyes","year":"2018","unstructured":"Noyes JD, Soto-Pedre E, Donnelly LA, et al. Characteristics of people with high visit-to-visit glycaemic variability in Type 2 diabetes. Diabet Med. 2018;35(2):262\u20139.","journal-title":"Diabet Med"},{"issue":"1","key":"1341_CR35","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12933-021-01318-2","volume":"20","author":"J Gumprecht","year":"2021","unstructured":"Gumprecht J, Lip GYH, Sokal A, et al. Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study. Cardiovasc Diabetol. 2021;20(1):128.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-021-01341-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-021-01341-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-021-01341-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T15:06:11Z","timestamp":1627052771000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-021-01341-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,23]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1341"],"URL":"https:\/\/doi.org\/10.1186\/s12933-021-01341-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-588082\/v1","asserted-by":"object"}]},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,23]]},"assertion":[{"value":"2 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol complies with the Declaration of Helsinki and was approved by the Institutional Review Board of National Taiwan University Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"148"}}